Half of Medicaid Patients Abandon Weight-Loss Drugs Within Months, Landmark Study Finds
A new claims-based study of nearly 4,000 Mississippi Medicaid members finds that adherence to GLP-1 weight-loss drugs plummets within months, ...
A new claims-based study of nearly 4,000 Mississippi Medicaid members finds that adherence to GLP-1 weight-loss drugs plummets within months, ...
A two-year Taiwanese cohort study using the new ESPEN–EASO consensus definition found that older adults with sarcopenic obesity—and a simpler ...
A randomized trial in Iran found that a legume-enriched DASH diet significantly improved weight, waist circumference, menstrual cycle duration, and ...
A Mount Sinai retrospective analysis suggests GLP-1 receptor agonists may reduce cardiovascular risk, inflammation, and disease severity in hidradenitis suppurativa.
A JAMA cross-sectional study quantifies how frequently commercially insured women in the United States begin GLP-1 receptor agonist prescriptions after ...
A four-year Chinese cohort study of 1,500 women found that overweight or obese patients with polyendocrine metabolic ovarian syndrome faced ...
A new JAMA Perspective argues that GLP-1 therapies must be embedded in multimodal obesity care combining screening, early management, and ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.